Navigation Links
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
Date:11/6/2012

n patients whose tumours express Fn14 might prevent cancer cells from growing and proliferating."

Fn14 is over-expressed in at least 30% of several solid tumours, including pancreatic cancer, breast cancer, non-small cell lung cancer and malignant melanoma.

From July 2011, Dr Lassen and his colleagues recruited 38 patients with treatment-refractory solid tumours to the phase I trial. All patients had tumours expressing the Fn14 receptor. They received an intravenous dose of the drug either once weekly or once every three weeks, with a dose range of 200 to 3600 mg.

Dr Lassen said: "Several of the patients continue to receive study treatments, and encouraging signs of clinical benefit have already been observed. A patient with heavily pre-treated, metastatic melanoma with no mutation in the BRAF gene has shown evidence of tumour regression when scanned using computerised tomography (CT) and remains on study after more than 30 weeks of treatment. Four other patients have had partial metabolic responses confirmed by positron emission tomography (PET) scans.

"Prolonged stable disease has been seen in several patients. Overall, 11 of the 38 patients (29%) have received more than 12 weeks of study treatment, with several receiving 18 or more weeks of RG7212 therapy, including those with refractory NSCLC, melanoma, mesothelioma, breast cancer, renal cell carcinoma, and biliary tract cancer.

"We found that RG7212 has an excellent safety profile across a broad dose range on each schedule. We saw no dose-limiting toxicities and no patient discontinued study treatments for treatment-related adverse side-effects. The phase I data show that RG7212 is quite safe for multi-cycle administration in patients with advanced cancer. Results from tests of blood and tumour samples suggest that it would be feasible to administer the drug over a prolonged period of time.

"There are encouraging pharmacodynamic data (effects of the drug on
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Elevated Antibody Levels May Predict Rheumatoid Arthritis Risk
2. NIH scientists map first steps in flu antibody development
3. Scientists Pinpoint Antibody That May Be Specific to MS Patients
4. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
5. Molecule found that inhibits recovery from stroke
6. Bloodstream scavenger inhibits clotting without increased bleeding
7. Laser-light testing of breast tumor fiber patterns helps show whose cancer is spreading
8. IU researchers report first effective treatment of tumors arising from common genetic disease NF1
9. Quality of Life After Cancer May Depend on Tumor Type
10. Socioeconomic disadvantage linked to breast cancer tumor disparity
11. Minorities most likely to have aggressive tumors, less likely to get radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Ottawa, ON (PRWEB) April 24, 2015 ... professional, safe, informed and legal access to medical cannabis, ... professionals are properly supported when advising patients. , NAC ... Cannabis Certificate Program. With a $250,000 grant, NAC will ... the program. , "Our goal is to help Canadians ...
(Date:4/24/2015)... MMJ Physician Practice in Salem, Massachusetts ... enroll in the Massachusetts medical marijuana program.    Their newly ... from Alternative Therapies Group (ATG), the first state-approved ... With the dispensary nearby, MMJ Physician Practice ... residents of eastern Massachusetts to enroll in the ...
(Date:4/24/2015)... 2015 Qualis Health, one of ... published a new resource for practicing physicians, “2013 ... to Quality and Resource Use Reports (QRUR) supplements ... Services (CMS) to help practices interpret their Medicare ... and identify care coordination opportunities to provide broader ...
(Date:4/24/2015)... Pa. (PRWEB) April 24, 2015 Nisan ... from Lewisburg, Pa. Trotter owns TrotFitness along with the ... trains clients and transforms lives. He was awarded the ... Fitness Business Summit. , Fitness Business Summit is a ... A sought-after marketing and business consultant, Keuilian created the ...
(Date:4/24/2015)... April 24, 2015 ProTube Outro is a ... X video editors. ProTube Outro allows editors to easily ... video drop zones. Position, scale, and rotate pictures/videos, logos, ... ProTube Outro uses simple borders and shadows for a minimalistic ... plugin. , ProTube Outro comes packed with over 30 customizable ...
Breaking Medicine News(10 mins):Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:Medical Doctor from Salem Massachusetts Supports the Medical Marijuana Industry 2Health News:Qualis Health Publishes Guide to Help Physician Practices Assess and Improve Quality 2Health News:Lewisburg Fitness Trainer Named 2015 Personal Trainer of the Year 2Health News:Lewisburg Fitness Trainer Named 2015 Personal Trainer of the Year 3Health News:Pixel Film Studios, FCPX Plugin Developer Announced the Release of Protube Outro, Outro Screen Templates for Final Cut Pro X 2
... Danaher Corporation,(NYSE: DHR ) announced that Executive ... will be presenting at the Goldman Sachs Global,Industrials ... 5, 2008 at,8:00 a.m. EST. The audio will ... Danaher Corporation is a leading manufacturer of Professional,Instrumentation, ...
... leaving ,hard-core, group behind, experts say , , TUESDAY, ... current smokers trying to kick the habit are now ... study finds. , In fact, nicotine dependence has risen ... of highly nicotine-dependent people has gone up 32 percent, ...
... 28 Nationwide,Health Properties, Inc. (NYSE: NHP ) ... per share dividend on our common stock that will,be ... on November 14, 2008., In addition, our Board ... Series B cumulative convertible preferred stock that will,be paid ...
... Vessels, Healthy ... Ability to Relax, ST. LOUIS, Oct. ... may enhance the function of arteries,in stroke patients, and help all Americans ... disease is the,nation,s number one killer while stroke is the third leading ...
... WellSpring Pharmaceutical,Corporation, a growing North American-based pharmaceutical ... Chief Operating Officer.,Formerly, Ms. Shusko held the position ... early 2000. In her new role as COO, ... areas of oversight,to operations with an initial focus ...
... help consumers get,accurate, dependable information about healthcare ... support consumer,engagement and improved quality in healthcare, ... consumer-focused, internet-based public,reporting. These guidelines will assist ... in an evidence-based and,consumer-friendly format that can ...
Cached Medicine News:Health News:Today's Smokers More Addicted to Nicotine 2Health News:Today's Smokers More Addicted to Nicotine 3Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:Study Shows How Soy Compound Lowers Blood Pressure and Stroke Risk 2Health News:WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 3Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 4Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 5
(Date:4/24/2015)... -- Hospira, Inc. (NYSE: HSP ), ... spoke about the importance of extrapolation in bringing biosimilars ... annual European Biosimilars Group conference in London ... publication of a pivotal white paper titled, "Why ... biosimilars." Speaking at the EGA conference, ...
(Date:4/23/2015)... -- Edwards Lifesciences Corporation (NYSE: EW ), the global ... monitoring, today reported net income for the quarter ended ... share.  Net income for the same period a year ... and non-GAAP net income was $82.1 million, or $0.76 ... quarter ended March 31, 2015 increased 13.0 percent to $590.3 ...
(Date:4/23/2015)... 23, 2015  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... first quarter financial results on Thursday, May 7, 2015, ... will host a live audio webcast immediately following the ... first quarter 2015 financial results and provide a business ... the live audio webcast via the Investors & Media ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2
... YORK, Sept. 15, 2011 Close to 100 openly HIV-positive ... around the world have signed a new letter ( http://tinyurl.com/pozPrEPletter ... than on fear or misinformation," of the challenges and opportunities ... and bisexual men and transgender women. The new open letter ...
... Qualitest Pharmaceuticals today issued a voluntary, nationwide, retail-level ... is being implemented because of a packaging error, where ... reversing the weekly tablet orientation and making the lot ... error and the potential for this error to have ...
Cached Medicine Technology:Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP) 2Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP) 3Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives 2
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Coronary angiographic catheter...
The advanced center-of-the-arc system allows an infinite choice of trajectories. The system's lightweight durable frame provides accuracy, simplicity, patient mobility and accessibility....
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package....
Medicine Products: